Zinc levels may predict worse outcomes with alopecia

Zinc levels may predict worse outcomes with alopecia

(HealthDay)—Lower serum zinc levels are associated with worse outcomes in patients with alopecia areata, according to a study published online July 3 in the International Journal of Dermatology.

Nermeen S.A. Abdel Fattah, M.D., from Ain Shams University in Cairo, and colleagues compared serum zinc levels between patients with newly diagnosed (25 participants) and resistant lesions of (25 participants) and in age- and sex-matched healthy controls (50 participants).

The researchers found that patients with alopecia areata had significantly lower serum zinc levels, compared to controls. Patients with resistant alopecia areata also had significantly lower zinc levels compared to patients with newly diagnosed disease. There was a significant inverse correlation between serum zinc level, severity of disease, and disease duration in all patients, as well as in patients with resistant alopecia areata.

"Assessment of serum zinc level in patients with alopecia areata appears useful as a marker of severity, disease duration, and resistance to therapies," the authors write. "Further studies are therefore recommended to evaluate the role of in with alopecia areata, especially those with severe, longstanding, or resistant lesions."

Explore further

Vitiligo, alopecia areata may up atopic dermatitis risk

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Zinc levels may predict worse outcomes with alopecia (2015, July 10) retrieved 4 March 2021 from https://medicalxpress.com/news/2015-07-zinc-worse-outcomes-alopecia.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments